Literature DB >> 2470266

Nasal histamine release following hyperosmolar and allergen challenge.

M C Krayenbuhl1, B N Hudspith, J Brostoff, G K Scadding, J L Guesdon, Y Latchman.   

Abstract

Allergic rhinitis is characterised by symptoms of sneezing, itching of the nose with watery secretions, and nasal obstruction. We have previously shown that patients can have the diagnosis of allergic rhinitis confirmed by nasal provocation tests and assessment of nasal inspiratory peak flow (NIPF) after specific allergen or hyperosmolar challenge. We now show that histamine is released into the nasal lavage fluid in response to such challenges. Saline lavage alone results in detectable histamine levels in the order of 5 ng/ml, but in the presence of allergen (HDM) there is a significant increase in histamine release in atopics but not in control subjects. With hyperosmolar challenge, atopics showed a biphasic response in that histamine release was increased with 1.8% and 3.6% saline but returned to baseline with 5.4% and 7.2% saline, then showing a further increase with 9.0% saline. This raises the possibility of two populations of responsive mast cells. Hyperosmolar challenge leads to symptoms of nasal itch and sneezing as well as histamine release in atopics but not in controls. This suggests that hyperosmolar challenge can be used as a simple diagnostic test for allergic rhinitis and may provide a model for nasal hyper-reactivity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2470266     DOI: 10.1111/j.1398-9995.1989.tb00441.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  2 in total

1.  Immune cell infiltration and broncovascular remodeling after nitric acid nasal instillation in a mouse bronchiolitis obliterans model.

Authors:  A L Garippo; E R Parra; W R Teodoro; A P Veloza; N H Yoshinari; V L Capelozzi
Journal:  Lung       Date:  2006 Jul-Aug       Impact factor: 2.584

2.  Tap water nasal irrigation in adults with seasonal allergic rhinitis: a randomized double-blind study.

Authors:  Min Xiong; Xiaoyan Fu; Wenting Deng; Huangwen Lai; Chuanhong Yang
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-04       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.